The legal action, spearheaded by Pomerantz LLP, centers on whether Wise and its leadership misled shareholders regarding the company's business practices. Scrutiny intensified on June 1, 2026, when Reuters reported that the Brussels Public Prosecutor’s Office was investigating Wise’s European entity for alleged connections to corruption, fraud, and drug trafficking. The report suggested that over $582.5 million in suspicious transactions had passed through the platform, triggering a two-day stock slide that saw shares drop nearly 10 percent.

Market pressure compounded on July 24, 2026, after The Wall Street Journal revealed that U.S. regulators denied Wise a national trust bank license. Officials cited significant deficiencies in the firm’s anti-money laundering and counter-terrorism financing programs. The announcement prompted a further 6.2 percent decline in share value, closing at $11.33. Investors seeking to participate in the class action are directed to contact Danielle Peyton at Pomerantz LLP by the end of September.